Literature DB >> 6350725

Roentgenographically occult lung cancer. A ten-year experience.

D A Cortese, P C Pairolero, E J Bergstralh, L B Woolner, M A Uhlenhopp, J M Piehler, D R Sanderson, P E Bernatz, D E Williams, W F Taylor, W S Payne, R S Fontana.   

Abstract

During the past 10 years, 54 patients, all men, were found to have roentgenographically occult lung cancer. The mean age was 61 years (range 45 to 76 years). All patients had abnormal findings on sputum cytologic study (carcinoma in 41 patients and squamous cell atypia in 13). The cancer was localized by bronchoscopy in all patients (range one to five examinations, mean 1.5). Seventy-five percent of the tumors were localized within 169 days of the abnormal sputum cytologic examination. Pulmonary resection for cure was performed in all patients: lobectomy in 38, pneumonectomy in nine, and bilobectomy in seven. Operative mortality was 5.6% (three patients). Fifty-eight cancers were resected, all squamous cell carcinomas (two had a component of large cell cancer). Tumor TNM classification (AJC) was TIS N0 M0 in 19 patients, T1 N0 M0 in 25, T1 N1 M0 in five, T2 N1 M0 in four, and T3 N0 M0 in one. Overall 5 year actuarial survival rate (lung cancer deaths only) was 90%. Five-year survival rate for the 44 patients with TIS N0 M0 and T1 N0 M0 neoplasms was 91%. Currently, 21 patients have died, but only 10 of lung cancer. Subsequent additional lung cancer developed in 12 patients (22%). Eleven of these patients had a second primary squamous lung cancer, six of which again were occult. We conclude that patients with occult lung cancer have a strong likelihood of long-term survival if treated early. Close surveillance is indicated because of the high incidence of a second primary lung cancer.

Entities:  

Mesh:

Year:  1983        PMID: 6350725

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  14 in total

Review 1.  Early central airways lung cancer.

Authors:  Chiaki Endo; Akira Sakurada; Takashi Kondo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-19

Review 2.  Techniques of endoscopic airway tumor treatment.

Authors:  Nicolas Guibert; Laurent Mhanna; Sylvain Droneau; Gavin Plat; Alain Didier; Julien Mazieres; Christophe Hermant
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Predictive value of sputum cytology.

Authors:  J Benbassat; A Regev; P E Slater
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

4.  Detection and minimally invasive treatment of early squamous lung cancer.

Authors:  Johannes M A Daniels; Thomas G Sutedja
Journal:  Ther Adv Med Oncol       Date:  2013-07       Impact factor: 8.168

Review 5.  Early detection for lung cancer. New tools for casefinding.

Authors:  S Lam; B Lam; T L Petty
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

6.  Detection of pre-invasive endobronchial tumors with D-light/autofluorescence system.

Authors:  Tae Won Jang; Chul Ho Oak; Bong Kwon Chun; Mann Hong Jung
Journal:  J Korean Med Sci       Date:  2006-04       Impact factor: 2.153

7.  Detection and localization of intraepithelial neoplasia and invasive carcinoma using fluorescence-reflectance bronchoscopy: an international, multicenter clinical trial.

Authors:  Eric Edell; Stephen Lam; Harvey Pass; York E Miller; Thomas Sutedja; Timothy Kennedy; Gregory Loewen; Robert L Keith; Adi Gazdar
Journal:  J Thorac Oncol       Date:  2009-01       Impact factor: 15.609

8.  Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

Authors:  John Yee; Marianne D Sadar; Don D Sin; Michael Kuzyk; Li Xing; Jennifer Kondra; Annette McWilliams; S F Paul Man; Stephen Lam
Journal:  J Clin Oncol       Date:  2009-05-04       Impact factor: 44.544

9.  HAEMOPTYSIS - INDICATIONS FOR BRONCHOSCOPY.

Authors:  A K Mehta; P C Chamyal
Journal:  Med J Armed Forces India       Date:  2017-06-27

10.  Is investigation of patients with haemoptysis and normal chest radiograph justified?

Authors:  M Thirumaran; R Sundar; I M Sutcliffe; D C Currie
Journal:  Thorax       Date:  2009-05-19       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.